Drug Trial Radar · NCT06987500
A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
132
Planned (sponsor's estimate)
Start
Apr 11, 2025
Primary completion
Feb 14, 2027
Study completion Aug 16, 2027
Sponsor
- Lead sponsor
- Evopoint Biosciences Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- First posted
- May 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize the safety, tolerability, and efficacy of XNW29016 in participants with advanced solid tumors .
Conditions
- Tumor, Solid
Interventions
XNW29016Drug
Oral Medication. The study set 7 dose level cohorts in dose escalation part.
XNW29016Drug
Oral Medication
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ph Ia/Ib: Overall safety profile including adverse eventsTime frame: Baseline up to approximately 2 years
- Ph Ia/Ib: Recommended phase 2 doses (RP2D) of XNW29016Time frame: Approximately 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
17 South Li, Panjiayuan, Chaoyang District, Beijing City.
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.